Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study

Human Brain Mapping

Volumn 35, Issue 8, 2014, Pages 3903-3918

  Shi, Jie ^a   Leporé, Natasha ^b   Gutman, Boris A ^c   Thompson, Paul M ^d,e   Baxter, Leslie C ^f   Caselli, Richard J ^g   Wang, Yalin ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BARROW NEUROLOGICAL INSTITUTE   (United States)

^g MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; APOE e4; Hippocampus; MRI; Multivariate tensor based morphometry

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN COMPUTER INTERFACE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MORPHOMETRICS; MULTIVARIATE TENSO RBASED MORPHOMETRY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; COHORT ANALYSIS; FACTUAL DATABASE; GENETICS; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; MULTIVARIATE ANALYSIS; PATHOLOGY;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FUNCTIONAL LATERALITY; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MILD COGNITIVE IMPAIRMENT; MULTIVARIATE ANALYSIS;

EID: 84903942060     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22447     Document Type: Article

References (116)

1. AIBL (2013): The Australian Imaging, Biomarkers & Lifestyle Flagship Study of Ageing, http://www.aibl.csiro.au/.
2. Apostolova LG, Morra JH, Green AE, Hwang KS, Avedissian C, Woo E, Cummings JL, Toga AW, Jack CR Jr, Weiner MW, Thompson PM (2010a): Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage 51:488-499
3. Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, Mistur R, Tsui WH, de Leon MJ (2010b): Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging 31:1077-1088.
4. Apostolova LG, Thompson PM, Green AE, Hwang KS, Zoumalan C, Jack CR Jr, Harvey DJ, Petersen RC, Thal LJ, Aisen PS, Toga AW, Cummings JL, Decarli CS. (2010c): 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp 31:786-797.
5. Arsigny V, Fillard P, Pennec X, Ayache N (2006): Log-Euclidean metrics for fast and simple calculus on diffusion tensors. Magn Reson Med 56:411-421.
6. Bansal R, Geiger B, Banihashemi A, Krishnan A (2000): Integrated segmentation, registration and visualization of multimodal medical image datasets. In: IEEE Visualization.
7. Bartley AJ, Jones DW, Weinberger DR (1997): Genetic variability of human brain size and cortical gyral patterns. Brain 120:257-269.
8. Benjamini Y, Hochberg Y (1995): Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289-300.
9. Bennett DA, De Jager PL, Leurgans SE, Schneider JA (2009): Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology 72:1495-1503.
10. Berg L (1988): Clinical dementia rating (CDR). Psychopharmacol Bull 24:637-639.
11. Bro-Nielsen M, Gramkow C (1996): Fast fluid registration of medical images. In: Visualization in Biomedical Computing (VBC'96). Germany: Springer. pp 267-276.
12. 2 fields. Ann Statist 27:925-942.
13. Cardenas VA, Chao LL, Studholme C, Yaffe K, Miller BL, Madison C, Buckley ST, Mungas D, Schuff N, Weiner MW (2011): Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol Aging 32:572-580.
14. Caselli RJ, Dueck AC, Locke DE, Sabbagh MN, Ahern GL, Rapcsak SZ, Baxter LC, Yaari R, Woodruff BK, Hoffman-Snyder C, Rademakers R, Findley S, Reiman EM. (2011): Cerebrovascular risk factors and preclinical memory decline in healthy APOE epsilon4 homozygotes. Neurology 76:1078-1084.
15. Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM. (2009): Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 361:255-263.
16. Caselli RJ, Walker D, Sue L, Sabbagh M, Beach T (2010): Amyloid load in nondemented brains correlates with APOE e4. Neurosci Lett 473:168-171.
17. Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J. (2007): Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. Am J Psychiatry 164:916-921.
18. Cho Y, Seong JK, Shin SY, Jeong Y, Kim JH, Qiu A, Im K, Lee JM, Na DL (2011): A multi-resolution scheme for distortion-minimizing mapping between human subcortical structures based on geodesic construction on Riemannian manifolds. Neuroimage 57:1376-1392.
19. Chou Y, Lepore N, Avedissian C, Madsen SK, Parikshak N, Hua X, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM. (2009): Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage 46:394-410.
20. Chung MK (2012): Computational Neuroanatomy: The Methods. World Scientific Publishing Company, Singapore.
21. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993): Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
22. Costafreda SG, Dinov ID, Tu Z, Shi Y, Liu CY, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Wahlund LO, Spenger C, Toga AW, Lovestone S. (2011): Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage 56: 212-219.
23. Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI (2000): Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology 55:1636-1643.
24. D'Agostino E, Maes F, Vandermeulen D, Suetens P (2003): A viscous fluid model for multimodal non-rigid image registration using mutual information. Med Image Anal 7:565-575.
25. Davatzikos C, Vaillant M, Resnick SM, Prince JL, Letovsky S, Bryan RN (1996): A computerized approach for morphological analysis of the corpus callosum. J Comput Assist Tomogr 20:88-97.
26. Dean DC III, Jerskey BA, Chen K, Protas H, Thiyyagura P, Roontiva A, O'Muricheartaigh J, Dirks H, Waskiewicz N, Lehman K, Siniard AL, Turk MN, Hua X, Madsen SK, Thompson PM, Fleisher AS, Huentelman MJ, Deoni SCL, Reiman EM. (2013): Brain imaging differences in infants at differential genetic risk for late-onset Alzheimer's disease. JAMA Neurol. doi: 10.1001/jamaneurol.2013.4544.
27. den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, Niessen WJ, Breteler MMB (2010): A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain 133:1163-1172.
28. Dewey J, Hana G, Russell T, Price J, McCaffrey D, Harezlak J, Sem E, Anyanwu JC, Guttmann CR, Navia B, Cohen R, Tate DF. (2010): Reliability and validity of MRI-based automated volumetry software relative to auto-assisted manual measurement of subcortical structures in HIV-infected patients from a multisite study. Neuroimage 51:1334-1344.
29. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK (1992): Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179-189.
30. Elad M, Milanfar P, Golub GH (2004): Shape from moments-An estimation theory perspective. Trans Sig Proc 52:1814-1829.
31. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D. (2009): The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21:672-687.
32. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997): Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349-1356.
33. Ferrarini L, Palm WM, Olofsen H, van der Landen R, van Buchem MA, Reiber JHC, Admiraal-Behloul F (2008): Ventricular shape biomarkers for Alzheimer's disease in clinical MR images. Magn Reson Med 59:260-267.
34. Folstein MF, Folstein SE, McHugh PR (1975): "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
35. Fox NC, Scahill RI, Crum WR, Rossor MN (1999): Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 52:1687-1689.
36. Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM (2010): The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67-77.
37. Gerdes LU, Klausen IC, Sihm I, Faergeman O (1992): Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 9:155-167.
38. Gerig G, Styner M, Jones D, Weinberger D, Lieberman M (2001). Shape analysis of brain ventricles using SPHARM. In: IEEE Workshop on Mathematical Methods in Biomedical Image Analysis (MMBIA'01).
39. Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S (1997): Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol 41:402-404.
40. Gu X, Vemuri B (2004): Matching 3D Shapes Using 2D Conformal Representations. Med Image Comp Comput Assist Interv 3216:771-780.
41. Gu X, Wang Y, Yau S-T (2004): Geometric compression using riemann surface structure. Commun Inf Syst 3:171-182.
42. Gutman B, Wang Y, Morra J, Toga AW, Thompson PM (2009): Disease classification with hippocampal shape invariants. Hippocampus 19:572-578.
43. Haller JW, Christensen GE, Joshi SC, Newcomer JW, Miller MI, Csernansky JG, Vannier MW (1996): Hippocampal MR imaging morphometry by means of general pattern matching. Radiology 199:787-791.
44. Han X, Xu C, Prince JL (2003): A topology preserving level set method for geometric deformable models. IEEE Trans Pattern Anal Mach Intell 25:755-768.
45. Holland D, Brewer JB, Hagler DJ, Fenema-Notestine C, Dale AM (2009): Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci USA 106:20954-20959.
46. Holmes AP, Blair RC, Watson JD, Ford I (1996): Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab 16:7-22.
47. Hotelling H (1931): The generalization of Student's ratio. Ann Math Statist 2:360-378.
48. Hua X, Gutman B, Boyle C, Rajagopalan P, Leow AD, Yanovsky I, Kumar AR, Toga AW, Jack CR Jr, Schuff N, Alexander GE, Chen K, Reiman EM, Weiner MW, Thompson PM. (2011): Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry. Neuroimage 57:5-14.
49. Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM. (2010): Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals. Neuroimage 51:63-75.
50. Hyman BT (2011): Amyloid-dependent and amyloid-independent stages of Alzheimer disease. Arch Neurol 68:1062-1064.
51. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell JL, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW. (2008): The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685-691.
52. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC. (2004): Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62:591-600.
53. Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O'Brien PC, Cha R, Knopman D, Petersen RC. (2003): MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 60:253-260.
54. Joshi SC, Miller MI (2000): Landmark matching via large deformation diffeomorphisms. IEEE Trans Image Process 9:1357-1370.
55. Kim WH, Pachauri D, Hatt C, Chung MK, Johnson SC, Singh V (2012): Wavelet based multi-scale shape features on arbitrary surfaces for cortical thickness discrimination. In: NIPS. pp 1250-1258.
56. Knickmeyer RC, Wang J, Zhu H, Geng X, Woolson S, Hamer RM, Konneker T, Lin W, Styner M, Gilmore JH (2013): Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex. DOI: 10.1093/cercor/bhs401
57. Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, Karhunen PJ (2009): Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650-657.
58. Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Partanen K, Ryynanen M, Vainio P, Hartikainen P, Riekkinen PJ Sr. (1995): Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 67:65-72.
59. Lemaitre H, Crivello F, Dufouil C, Grassiot B, Tzourio C, Alperovitch A, Mazoyer B (2005): No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24:1205-1213.
60. Leow A, Huang SC, Geng A, Becker J, Davis S, Toga A, Thompson P (2005): Inverse consistent mapping in 3D deformable image registration: Its construction and statistical properties. Inf Process Med Imaging 19:493-503.
61. Lepore N, Brun C, Chou Y-Y, Chiang M-C, Dutton RA, Hayashi KM, Luders E, Lopez OL, Aizenstein HJ, Toga AW, Becker JT, Thompson PM. (2008): Generalized tensor-based morphometry of HIV/AIDS using multivariate statistics on deformation tensors. IEEE Trans Med Imag 27:129-141.
62. Lorensen WE, Cline HE (1987): Marching cubes: A high resolution 3D surface construction algorithm. SIGGRAPH Comput Graph 21:163-169.
63. Luders E, Thompson PM, Kurth F, Hong JY, Phillips OR, Wang Y, Gutman BA, Chou YY, Narr KL, Toga AW (2012): Global and regional alterations of hippocampal anatomy in long-term meditation practitioners. Hum Brain Mapp 34:3369-3375.
64. Madsen SK, Ho AJ, Hua X, Saharan PS, Toga AW, Jack CR Jr, Weiner MW, Thompson PM (2010): 3D maps localize caudate nucleus atrophy in 400 AD, MCI, and healthy elderly subjects. Neurobiol Aging 31:1312-1325.
65. Miller G (2009): Alzheimer's biomarker initiative hits its stride. Science 326:386-389.
66. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM. (2009a): Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp 30:2766-2788.
67. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM. (2009b): Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage 45:S3-S15.
68. Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA (2010): APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67:122-131.
69. Mueller SG, Weiner MW (2009): Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus 19:558-564.
70. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L (2005a): The Alzheimer's disease neuroimaging initiative. Neuroimag Clin N Am 15:869-877.
71. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L (2005b): Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's disease neuroimaging initiative (ADNI). Alzheimers Dement 1:55-66.
72. Nichols TE, Holmes AP (2002): Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum Brain Mapp 15:1-25.
73. Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011): A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907-922.
74. Pievani M, Galluzzi S, Thompson PM, Rasser PE, Bonetti M, Frisoni GB (2011): APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease. Neuroimage 55:909-919.
75. Pizer S, Fritsch D, Yushkevich P, Johnson V, Chaney E (1999): Segmentation, registration, and measurement of shape variation via image object shape. IEEE Trans Med Imag 18:851-865.
76. Poline JB, Vandenberghe R, Holmes AP, Friston KJ, Frackowiak RS (1996): Reproducibility of PET activation studies: Lessons from a multi-center European experiment. EU concerted action on functional imaging. Neuroimage 4:34-54.
77. Qiu A, Brown T, Fischl B, Ma J, Miller MI (2010): Atlas generation for subcortical and ventricular structures with its applications in shape analysis. IEEE Trans Image Process 19:1539-1547.
78. Qiu A, Taylor WD, Zhao Z, MacFall JR, Miller MI, Key CR, Payne ME, Steffens DC, Krishnan KR (2009): APOE related hippocampal shape alteration in geriatric depression. Neuroimage 44:620-626.
79. Reiman EM (2007): Linking brain imaging and genomics in the study of Alzheimer's disease and aging. Ann N Y Acad Sci 1097:94-113.
80. Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J (2001): Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci USA 98:3334-3339.
81. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996): Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334:752-758.
82. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J (2005): Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA 102:8299-8302.
83. Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ. (2009): Fibrillaramyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 106:6820-6825.
84. Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, de Leon MJ, De Santi S, Convit A, Osborne D, Weaver A, Thibodeau SN. (1998): Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 44:288-291.
85. Rey D, Subsol G, Delingette H, Ayache N (2002): Automatic detection and segmentation of evolving processes in 3D medical images: Application to multiple sclerosis. Med Image Anal 6:163-179.
86. Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC. (2008): Volumetric MRI and cognitive measures in Alzheimer disease: Comparison of markers of progression. J Neurol 255:567-574.
87. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD. (1993): Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
88. Shen L, Firpi HA, Saykin AJ, West JD (2009): Parametric surface modeling and registration for comparison of manual and automated segmentation of the hippocampus. Hippocampus 19:588-595.
89. Shi J, Thompson PM, Gutman B, Wang Y (2013a): Surface fluid registration of conformal representation: Application to detect disease burden and genetic influence on hippocampus. Neuroimage 78C:111-134.
90. Shi J, Wang Y, Ceschin R, An X, Lao Y, Vanderbilt D, Nelson MD, Thompson PM, Panigrahy A, Lepore N (2013b): A multivariate surface-based analysis of the putamen in premature newborns: Regional differences within the ventral striatum. PLoS One 8:e66736.
91. Smith H, Gnanadesikan R, Hughes JB (1962): Multivariate analysis of variance (MANOVA). Biometrics 18:22-41.
92. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. (2011): Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280-292.
93. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann O, Bernard M, et al. (2012): Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44:552-561.
94. Stonnington CM, Chu C, Kloppel S, Jack CR Jr, Ashburner J, Frackowiak RS (2010): Predicting clinical scores from magnetic resonance scans in Alzheimer's disease. Neuroimage 51:1405-1413.
95. Styner M, Lieberman JA, McClure RK, Weinberger DR, Jones DW, Gerig G (2005): Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors. Proc Natl Acad Sci USA 102:4872-4877.
96. Styner M, Lieberman JA, Pantazis D, Gerig G (2004): Boundary and medial shape analysis of the hippocampus in schizophrenia. Med Image Anal 8:197-203.
97. Thirion JP, Prima S, Subsol G, Roberts N (2000): Statistical analysis of normal and abnormal dissymmetry in volumetric medical images. Med Image Anal 4:111-121.
98. Thompson PM, Hayashi KM, de Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW. Mapping hippocampal and ventricular change in Alzheimer's disease. Neuroimage 22:1754-1766.
99. Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria M, Toro R, Jahanshad N, Schumann G, Franke B, et al. The ENIGMA Consortium: Large-scale Collaborative Analyses of Neuroimaging and Genetic Data. Brain Imaging and Behavior. (in press).
100. Van Leemput K, Bakkour A, Benner T, Wiggins G, Wald LL, Augustinack J, Dickerson BC, Golland P, Fischl B (2009): Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 19:549-557.
101. Vemuri P, Gunter JL, Senjem ML, Whitwell JL, Kantarci K, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr (2008a): Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies. Neuroimage 39:1186-1197.
102. Vemuri P, Whitwell JL, Kantarci K, Josephs KA, Parisi JE, Shiung MS, Knopman DS, Boeve BF, Petersen RC, Dickson DW, Jack CR Jr. (2008b): Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. Neuroimage 42:559-567.
103. Wang L, Beg F, Ratnanather T, Ceritoglu C, Younes L, Morris JC, Csernansky JG, Miller MI (2007): Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type. IEEE Trans Med Imaging 26:462-470.
104. Wang L, Miller JP, Gado MH, McKeel DW, Rothermich M, Miller MI, Morris JC, Csernansky JG (2006): Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type. Neuroimage 30:52-60.
105. Wang L, Swank JS, Glick IE, Gado MH, Miller MI, Morris JC, Csernansky JG (2003): Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage 20:667-682.
106. Wang Y, Chan TF, Toga AW, Thompson PM (2009): Multivariate tensor-based brain anatomical surface morphometry via holomorphic one-forms. Med Image Comp Comput Assist Interv 12:337-344.
107. Wang Y, Shi J, Yin X, Gu X, Chan TF, Yau S-T, Toga AW, Thompson PM (2012): Brain surface conformal parameterization with the ricci flow. IEEE Trans Med Imag 31:251-264.
108. Wang Y, Song Y, Rajagopalan P, An T, Liu K, Chou YY, Gutman B, Toga AW, Thompson PM (2011): Surface-based TBM boosts power to detect disease effects on the brain: An N = 804 ADNI study. Neuroimage 56:1993-2010.
109. Wang Y, Yuan L, Shi J, Greve A, Ye J, Toga AW, Reiss AL, Thompson PM (2013): Applying tensor-based morphometry to parametric surfaces can improve MRI-based disease diagnosis. Neuroimage 74:209-230.
110. Wang Y, Zhang J, Gutman B, Chan TF, Becker JT, Aizenstein HJ, Lopez OL, Tamburo RJ, Toga AW, Thompson PM (2010): Multivariate tensor-based morphometry on surfaces: Application to mapping ventricular abnormalities in HIV/AIDS. Neuroimage 49:2141-2157.
111. Wechsler D (1987): Wechsler Memory Scale-Revised Manual. San Antonio, TX: Psychological Corporation.
112. Wolz R, Heckemann RA, Aljabar P, Hajnal JV, Hammers A, Lötjönen J, Rueckert D (2010): Measurement of hippocampal atrophy using 4D graph-cut segmentation: Application to ADNI. Neuroimage 52:109-118.
113. Yang X, Goh A, Chen SH, Qiu A (2012): Evolution of hippocampal shapes across the human lifespan. Hum Brain Mapp 34:3075-3085
114. Yassa MA, Stark SM, Bakker A, Albert MS, Gallagher M, Stark CE (2010): High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic mild cognitive impairment. Neuroimage 51:1242-1252.
115. Yushkevich PA, Wang H, Pluta J, Das SR, Craige C, Avants BB, Weiner MW, Mueller S (2010): Nearly automatic segmentation of hippocampal subfields in in vivo focal T2-weighted MRI. Neuroimage 53:1208-1224.
116. Zhang D, Lu G (2004): Review of shape representation and description techniques. Pattern Recognit 37:1-19.